New Owner
Gilead Sciences - Triangle Pharmaceuticals
Gilead Sciences acquires Triangle Pharmaceuticals
Announced: January 23, 2003
Type: Acquisition
Disposition: Combined
Terms: Cash & Stock
Status: Complete
Amount: $ 525,200,000